Compliance with the Current NCCN Guidelines and Its Critical Role in Pancreatic Adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Laboratory medicine"
DOI: 10.1093/labmed/lmac046
Abstract: OBJECTIVES Since 2019, the National Comprehensive Cancer Network (NCCN) has recommended genetic testing for patients diagnosed with pancreatic adenocarcinoma that includes universal germline testing and tumor gene profiling for metastatic, locally advanced, or recurrent disease.… read more here.
Keywords: tumor gene; germline testing; compliance; nccn guidelines ... See more keywords
Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy
Sign Up to like & getrecommendations! Published in 2017 at "Oncology Research and Treatment"
DOI: 10.1159/000481353
Abstract: The identification of human Wilms' tumor gene 1 (WT1) protein-derived cytotoxic T lymphocyte (CTL) epitopes and the in vivo efficacy of WT1 peptide-based immunotherapy in a mouse model were reported in 2000. This successful basic… read more here.
Keywords: tumor gene; clinical studies; peptide vaccine; vaccine ... See more keywords